BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37110684)

  • 1. Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells.
    Kim NY; Vishwanath D; Xi Z; Nagaraja O; Swamynayaka A; Kumar Harish K; Basappa S; Madegowda M; Pandey V; Sethi G; Lobie PE; Ahn KS; Basappa B
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway.
    Cao XH; Wang AH; Wang CL; Mao DZ; Lu MF; Cui YQ; Jiao RZ
    Chem Biol Interact; 2010 Feb; 183(3):357-62. PubMed ID: 19954742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
    Zhu X; Wang K; Zhang K; Zhu L; Zhou F
    Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1.
    Na HK; Kim EH; Choi MA; Park JM; Kim DH; Surh YJ
    Biochem Pharmacol; 2012 Nov; 84(10):1241-50. PubMed ID: 22981381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ω-hydroxyundec-9-enoic acid induces apoptosis by ROS mediated JNK and p38 phosphorylation in breast cancer cell lines.
    Ahn J; Chung YW; Park JB; Yang KM
    J Cell Biochem; 2018 Jan; 119(1):998-1007. PubMed ID: 28681938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells.
    Lin MH; Cheng CH; Chen KC; Lee WT; Wang YF; Xiao CQ; Lin CW
    Chem Biol Interact; 2014 Jul; 218():42-9. PubMed ID: 24812029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro.
    Singh RK; Dorf L; DeMartino A; Illenye S; Koto K; Currier EA; Ashikaga T; Kim KK; Brard L; Sholler GL
    Cancer Biol Ther; 2011 Jun; 11(12):1036-45. PubMed ID: 21532338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.
    Wang L; Wang C; Tao Z; Zhao L; Zhu Z; Wu W; He Y; Chen H; Zheng B; Huang X; Yu Y; Yang L; Liang G; Cui R; Chen T
    J Exp Clin Cancer Res; 2019 Nov; 38(1):460. PubMed ID: 31703744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells.
    Kuo PL; Chen CY; Tzeng TF; Lin CC; Hsu YL
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):215-26. PubMed ID: 18374381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.
    Cai G; Yu W; Song D; Zhang W; Guo J; Zhu J; Ren Y; Kong L
    Eur J Med Chem; 2019 Jul; 174():236-251. PubMed ID: 31048139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK.
    Gschwantler-Kaulich D; Grunt TW; Muhr D; Wagner R; Kölbl H; Singer CF
    PLoS One; 2016; 11(1):e0146311. PubMed ID: 26735495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
    Sun ZL; Dong JL; Wu J
    Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(4-hydroxy-2H-chromen-2-one) Coumarin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Aromatase Inhibition.
    Ramdani LH; Talhi O; Decombat C; Vermerie M; Berry A; Silva A; Bachari K; Vasson MP; Delort L; Caldefie-Chézet F
    Anticancer Res; 2019 Nov; 39(11):6107-6114. PubMed ID: 31704838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death.
    Bana E; Sibille E; Valente S; Cerella C; Chaimbault P; Kirsch G; Dicato M; Diederich M; Bagrel D
    Mol Carcinog; 2015 Mar; 54(3):229-41. PubMed ID: 24155226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
    Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desacetyl nimbinene inhibits breast cancer growth and metastasis through reactive oxygen species mediated mechanisms.
    Arumugam A; Subramani R; Nandy S; Powell S; Velazquez M; Orozco A; Galvez A; Lakshmanaswamy R
    Tumour Biol; 2016 May; 37(5):6527-37. PubMed ID: 26637227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
    Khan S; Zafar A; Naseem I
    Chem Biol Interact; 2018 Jun; 290():64-76. PubMed ID: 29803612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAD1822-7 induces ROS-mediated apoptosis of HER2 positive breast cancer by decreasing E-cadherin in an EphB4 dependent manner.
    Zhu M; Tang X; Gong Z; Tang W; Zhang Y
    Life Sci; 2021 Nov; 285():119954. PubMed ID: 34520770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
    Yang F; Nam S; Zhao R; Tian Y; Liu L; Horne DA; Jove R
    Cancer Biol Ther; 2013 Nov; 14(11):1024-31. PubMed ID: 24025361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.